Ocular Therapeutix Ownership & Insider Activity

SPY774.99−0.53%QQQ755.37−0.56%BTC/USD83,196.72−2.75%DIA509.14−1.05%GLD375.88−1.67%TLT76.91−0.48%

Ocular Therapeutix Inc

OCULNASDAQ

Trade with Public

$7.25

-0.09-1.23%

Last update: Oct 7, 9:28 AM

$7.25

-0.09-1.23%

Overview News Earnings Forecast Events Price Targets Financials SentimentOwnershipCompare Options Stock Report

Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix (OCUL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.7% of shares outstanding. Institutional investors hold 46.9%. Over the past 90 days, insiders made 7 sales worth $480K.

Shares Outstanding

219.616M

Shares Float

186.085M

Insider Shares Owned

8.192M

Insider % Owned

3.7%

Institutional Shares Held

103.041M

Institutional % Held

46.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$480K total

Net Activity

Net Selling

Net Value (90d)

-$480K

Ocular Therapeutix Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	9.990K	$7.05	$70K
Oct 2, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	10.869K	$7.05	$77K
Aug 31, 2026	Donald Notman	CHIEF OPERATING OFFICER	SELL	1.099K	$10.24	$11K
Aug 24, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	3.035K	$10.77	$33K
Aug 24, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.897K	$10.78	$20K
Aug 24, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.296K	$10.78	$36K
Aug 24, 2026	Pravin Dugel	SEE REMARKS	SELL	21.649K	$10.77	$233K
Jun 3, 2026	Nadia Waheed	CHIEF MEDICAL OFFICER	SELL	14.828K	$8.27	$123K
May 26, 2026	Pravin Dugel	SEE REMARKS	SELL	21.156K	$8.20	$173K
May 26, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	2.967K	$8.20	$24K
May 26, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.018K	$8.20	$25K
May 26, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.858K	$8.20	$15K

More with Benzinga EdgeGet Access

Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix (OCUL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.7% of shares outstanding. Institutional investors hold 46.9%. Over the past 90 days, insiders made 7 sales worth $480K.

Shares Outstanding

219.616M

Shares Float

186.085M

Insider Shares Owned

8.192M

Insider % Owned

3.7%

Institutional Shares Held

103.041M

Institutional % Held

46.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$480K total

Net Activity

Net Selling

Net Value (90d)

-$480K

Ocular Therapeutix Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	9.990K	$7.05	$70K
Oct 2, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	10.869K	$7.05	$77K
Aug 31, 2026	Donald Notman	CHIEF OPERATING OFFICER	SELL	1.099K	$10.24	$11K
Aug 24, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	3.035K	$10.77	$33K
Aug 24, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.897K	$10.78	$20K
Aug 24, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.296K	$10.78	$36K
Aug 24, 2026	Pravin Dugel	SEE REMARKS	SELL	21.649K	$10.77	$233K
Jun 3, 2026	Nadia Waheed	CHIEF MEDICAL OFFICER	SELL	14.828K	$8.27	$123K
May 26, 2026	Pravin Dugel	SEE REMARKS	SELL	21.156K	$8.20	$173K
May 26, 2026	Peter Kaiser	CHIEF DEVELOPMENT OFFICER	SELL	2.967K	$8.20	$24K
May 26, 2026	Jeffrey S Heier	CHIEF SCIENTIFIC OFFICER	SELL	3.018K	$8.20	$25K
May 26, 2026	Sanjay Nayak	CHIEF STRATEGY OFFICER	SELL	1.858K	$8.20	$15K

More with Benzinga EdgeGet Access

Ocular Therapeutix Inc

Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix Insider Transactions (Last 6 Months)

Ocular Therapeutix Ownership & Insider Activity

Ocular Therapeutix Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch